Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study.

Immunotargets Ther · 2025 · PMC12278979 · PMID 40693263

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

marginal significanceP=0.068so close (0.05 < p ≤ 0.1)

The crude OR was 5.33 with marginal significance (95% CI: 0.99–42.00, P=0.068).

also in 3,507 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.